Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
letter
. 1993 Mar;69(809):242. doi: 10.1136/pgmj.69.809.242

Aspirin and risk of fatal colon cancer.

M Odeh
PMCID: PMC2399724  PMID: 8497448

Full text

PDF

Page 242

242

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antonelli G., Mastino A., Amicucci P., Turriziani O., Favalli C., Garaci E. Mechanism of production of interferon-gamma: role of arachidonic acid metabolites. J Biol Regul Homeost Agents. 1990 Jan-Mar;4(1):13–18. [PubMed] [Google Scholar]
  2. Blottiere H. M., Douillard J. Y., Koprowski H., Steplewski Z. Humoral and cellular responses of colorectal cancer patients treated with monoclonal antibodies and interferon gamma. Cancer Immunol Immunother. 1990;32(1):29–37. doi: 10.1007/BF01741721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cesario T. C., Yousefi S., Carandang G. The regulation of interferon production by aspirin, other inhibitors of the cyclooxygenase pathway and agents influencing calcium channel flux. Bull N Y Acad Med. 1989 Jan;65(1):26–35. [PMC free article] [PubMed] [Google Scholar]
  4. Corkey B. E., Geschwind J. F., Deeney J. T., Hale D. E., Douglas S. D., Kilpatrick L. Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome. J Clin Invest. 1991 Mar;87(3):778–786. doi: 10.1172/JCI115081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fiedler W., Zeller W., Peimann C. J., Weh H. J., Hossfeld D. K. A phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer. Klin Wochenschr. 1991 Apr 4;69(6):261–268. doi: 10.1007/BF01666852. [DOI] [PubMed] [Google Scholar]
  6. Hsia J., Sarin N., Oliver J. H., Goldstein A. L. Aspirin and thymosin increase interleukin-2 and interferon-gamma production by human peripheral blood lymphocytes. Immunopharmacology. 1989 May-Jun;17(3):167–173. doi: 10.1016/0162-3109(89)90045-3. [DOI] [PubMed] [Google Scholar]
  7. Kune G. A., Kune S., Watson L. F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 1988 Aug 1;48(15):4399–4404. [PubMed] [Google Scholar]
  8. Larrick J. W., Kunkel S. L. Is Reye's syndrome caused by augmented release of tumour necrosis factor? Lancet. 1986 Jul 19;2(8499):132–133. doi: 10.1016/s0140-6736(86)91947-1. [DOI] [PubMed] [Google Scholar]
  9. Muro M., Naomoto Y., Orita K. Mechanism of the combined antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha on cell cycle progression. Jpn J Cancer Res. 1991 Jan;82(1):118–126. doi: 10.1111/j.1349-7006.1991.tb01754.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Numata A., Minagawa T., Asano M., Nakane A., Katoh H., Tanabe T. Functional evaluation of tumor-infiltrating mononuclear cells. Detection of endogenous interferon-gamma and tumor necrosis factor-alpha in human colorectal adenocarcinomas. Cancer. 1991 Nov 1;68(9):1937–1943. doi: 10.1002/1097-0142(19911101)68:9<1937::aid-cncr2820680916>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  11. Rosenberg L., Palmer J. R., Zauber A. G., Warshauer M. E., Stolley P. D., Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991 Mar 6;83(5):355–358. doi: 10.1093/jnci/83.5.355. [DOI] [PubMed] [Google Scholar]
  12. Schiller J. H., Storer B., Bittner G., Horisberger M. A. Characterization of the synergistic antiproliferative effects of interferon-gamma and tumor necrosis factor on human colon carcinoma cell lines. J Interferon Res. 1990 Apr;10(2):129–139. doi: 10.1089/jir.1990.10.129. [DOI] [PubMed] [Google Scholar]
  13. Thun M. J., Namboodiri M. M., Heath C. W., Jr Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593–1596. doi: 10.1056/NEJM199112053252301. [DOI] [PubMed] [Google Scholar]
  14. Toth C. A., Thomas P. The effect of interferon treatment on 14 human colorectal cancer cell lines: growth and carcinoembryonic antigen secretion in vitro. J Interferon Res. 1990 Dec;10(6):579–588. doi: 10.1089/jir.1990.10.579. [DOI] [PubMed] [Google Scholar]
  15. Wadler S., Lembersky B., Atkins M., Kirkwood J., Petrelli N. Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1991 Oct;9(10):1806–1810. doi: 10.1200/JCO.1991.9.10.1806. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES